Pay in 4 interest-free payments of $6.39 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The drug remains in active clinical development, with Phase 3 trials currently underway evaluating retatrutide's efficacy and safety across broader populations, including individuals with obesity, type 2 diabetes, and cardiovascular disease
These compounds are believed to enhance liver function and fat metabolism, aiding in weight loss
Therefore, GLP-1R agonists are currently being intensively studied for their use in the treatment of neurodegenerative diseases such as Alzheimers disease and Parkinsons disease [17, 18]
Our commitment to safety helps identify and address any potential adverse effects promptly
US$ 28.69
US$ 29.03
US$ 26.23
US$ 28.04
US$ 25.94
US$ 24.31
